Key result
A localized chronic increase in blood flow restored flow-mediated vasodilatation in small arteries of rats with chronic heart failure (28% vs 13%; P<0.05).
Absolute Event Rate: 28% vs 13%
p-value: p=<0.05
Endothelial dysfunction of small arteries in chronic heart failure appears to be largely driven by chronic decreases in blood flow, and can be reversed by restoring flow.
Flow restoration may reverse endothelial dysfunction in heart failure models; leaves open translation to human therapy.
Chronic heart failure (CHF) impairs endothelium-dependent, nitric oxide (NO)-mediated dilation. This decreased dilation may be partly secondary to the chronic decrease in blood flow, but this hypothesis has not yet been tested. Thus, we assessed whether a localized, chronic increase in blood flow in vivo reverses endothelial dysfunction of small arteries in rats with CHF. Two months after coronary artery ligation or sham surgery, second-order side branches of the superior mesenteric artery were ligated in order to obtain persistently elevated blood flow (HF) in the adjacent first-order side branch compared with normal vessels (NF). One month later, responses to acetylcholine and flow-mediated vasodilatation (FMD) were assessed in vitro in an arteriograph. Chronic heart failure induced a decrease in mesenteric blood flow (374 +/- 25 and 305 +/- 27 micro L/min for sham and CHF, respectively; P < 0.05). Neither CHF nor the chronic increase in flow affected the responses to acetylcholine. Chronic heart failure decreased FMD (maximal response in sham and control 34 +/- 6 and 13 +/- 4%, respectively; P < 0.05). Chronic increases in blood flow did not modify FMD in sham, but restored FMD in CHF rats (28 +/- 4%; P < 0.05 vs CHF NF). The restored response was abolished by an inhibitor of NO synthesis (N(G)-nitro-l-arginine). Chronic heart failure did not affect the abundance of mesenteric endothelial NO synthase (eNOS) mRNA. A chronic increase in flow significantly increased the abundance of eNOS mRNA in sham rats, but only moderately and non-significantly in CHF rats. Thus, endothelial dysfunction of small arteries in CHF appears to be largely the consequence of the chronic decrease in flow.
No takes yet. Share an insight, caveat, or question.
Iglarz et al. (2004) studied Chronic heart failure. Localized chronic increase in blood flow vs. Normal vessels (no chronic increase in flow) was evaluated on Flow-mediated vasodilatation (FMD) (p=<0.05). A localized chronic increase in blood flow restored flow-mediated vasodilatation in small arteries of rats with chronic heart failure (28% vs 13%; P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: